Sign in

CIK 0001710340

  • Non-accelerated filer
  • Smaller reporting company

Eton Pharmaceuticals, Inc.

Sign in to watch
Ticker
ETON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
371858472
Phone
+1 847-787-7361
Business address
21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
  1. 4 Open-market sale 10% owner sold 126,685 shares at an average $37.64 ($4,768,637)
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale Director sold 50,000 shares at $32.48 ($1,623,795)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale President & CEO sold 120,000 shares at an average $31.88 ($3,825,717)
  6. 4 Open-market sale Chief Business Officer sold 100,000 shares at an average $32.30 ($3,229,923)
  7. 4 Exercise or conversion Director acquired 32,155 shares (option exercise)
  8. 4 Option exercise Director acquired 30,000 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Shares withheld for taxes President & CEO gave up 5,015 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Business Officer gave up 1,942 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 2,293 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Commercial Officer gave up 85 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Business Officer gave up 6,264 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 4,542 shares (to pay taxes)
  20. 4 Shares withheld for taxes President & CEO gave up 6,732 shares (to pay taxes)

Page 2 of 7 · 133 filings